GO:0019883 antigen processing and presentation of endogenous antigen: Immune Surveillance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019883 describes how an antigen-presenting cell expresses endogenous antigen (peptide or lipid) on its surface in association with an MHC protein complex.
• The pathway is central to CD8+ T cell priming and immune surveillance, and its dysfunction is linked to cancer immune evasion and autoimmune pathology.
• Key molecular players include MHC class I heavy chain (HLA-A, HLA-B, HLA-C), beta-2-microglobulin (B2M), the proteasome subunits PSMB8 and PSMB9, and peptide transporters TAP1 and TAP2.
• Cross-presentation of dead-cell-associated antigens can be promoted by DNGR-1-dependent phagosomal rupture, expanding the repertoire of endogenous antigen presentation.
• Autophagy contributes to endogenous antigen processing and presentation, particularly for antigens delivered to MHC class II and cross-presentation pathways.
• CRISPR knockout, point mutation, knock-in, and overexpression cell models enable causal dissection of antigen processing genes and their roles in disease.
Description
Antigen processing and presentation of endogenous antigen (GO:0019883) is the biological process by which an antigen-presenting cell expresses peptides or lipids of endogenous origin on its cell surface in association with an MHC protein complex. This process is fundamental to adaptive immunity because it allows the immune system to monitor the intracellular environment for signs of infection or malignant transformation. The term encompasses the generation of antigenic peptides from cytosolic or nuclear proteins, their transport into the secretory pathway, and their loading onto MHC molecules for display to T cells. Researchers study GO:0019883 to understand how cytotoxic T lymphocytes recognize infected or transformed cells, and how tumors and pathogens evade this surveillance. The pathway is also critical for central tolerance induction in the thymus, where endogenous antigens shape the T cell repertoire. Defects in antigen processing and presentation are increasingly recognized as mechanisms of immune evasion in cancer and as contributors to autoimmunity and chronic infection.
antigen processing and presentation of endogenous antigen At A Glance
| GO ID | GO:0019883 |
|---|---|
| GO term | antigen processing and presentation of endogenous antigen |
| Ontology | biological_process |
| Synonym | antigen presentation, endogenous antigen |
| Major function | Surface display of endogenous peptide or lipid antigens in association with MHC protein complexes for T cell recognition |
| Cellular location | Cytosol, endoplasmic reticulum, Golgi, endosomes, and plasma membrane |
| Key molecular players | MHC class I heavy chain, B2M, proteasome subunits, TAP1/TAP2, tapasin, ERAP1 |
| Related processes | Cross-presentation, autophagy-mediated antigen presentation, central tolerance induction |
What Is GO:0019883?
GO:0019883 is defined as the process in which an antigen-presenting cell expresses antigen (peptide or lipid) of endogenous origin on its cell surface in association with an MHC protein complex. In simpler terms, it is the route by which proteins made inside a cell are chopped into fragments, carried to the cell surface by MHC molecules, and shown to immune cells. This definition distinguishes endogenous antigen presentation from presentation of antigens taken up from outside the cell, although cross-presentation pathways can intersect with this process.
Why Is antigen processing and presentation of endogenous antigen Important in Cell Biology?
GO:0019883 is essential for immune surveillance because it enables CD8+ T cells to detect intracellular pathogens and malignant cells. The pathway also plays a central role in central tolerance, where endogenous antigens presented in the thymus contribute to the elimination of self-reactive T cells. Dysregulation of endogenous antigen presentation is a common mechanism of tumor immune evasion, and defects in this pathway can limit the efficacy of cancer immunotherapies. Understanding the molecular steps of GO:0019883 is therefore critical for vaccine development, immunotherapy design, and the interpretation of autoimmune and infectious disease pathology.
• Enables CD8+ T cell recognition of virus-infected cells and tumor cells.
• Supports central tolerance by presenting endogenous self-antigens in the thymus.
• Tumor immune evasion frequently involves defects in antigen processing and presentation.
• Cross-presentation of dead-cell-associated antigens can intersect with endogenous presentation pathways.
• Autophagy contributes to endogenous antigen processing and presentation.
• Bacterial modulation of antigen processing and presentation can alter host immune responses.
• Genome-wide methods such as T-Scan enable systematic discovery of T cell epitopes derived from endogenous antigens.
• MHC-I dynamics in the antigen processing pathway are critical for efficient peptide loading and surface display.
• Defects in this pathway are relevant to cancer vaccine development and immunotherapy resistance.
• The pathway is a target for experimental manipulation using CRISPR-based cell models.
What Happens During antigen processing and presentation of endogenous antigen?
Generation of endogenous peptides by the proteasome
In simple terms: Proteins inside the cell are cut into small pieces by a molecular shredder called the proteasome.
Endogenous proteins, including viral proteins and tumor antigens, are degraded in the cytosol by the proteasome. Immunoproteasome subunits such as PSMB8 and PSMB9 can be induced to enhance the generation of peptides suitable for MHC class I presentation. The resulting peptide fragments are then available for transport into the endoplasmic reticulum.
Peptide transport into the endoplasmic reticulum by TAP
In simple terms: A transporter carries the peptide pieces into a compartment where they can meet MHC molecules.
The transporter associated with antigen processing (TAP), composed of TAP1 and TAP2, translocates cytosolic peptides into the endoplasmic reticulum. This step is essential for loading peptides onto MHC class I molecules, and defects in TAP function impair endogenous antigen presentation.
Peptide loading onto MHC class I and surface display
In simple terms: The peptide is loaded onto an MHC molecule, which then carries it to the cell surface for immune inspection.
In the endoplasmic reticulum, MHC class I heavy chain associates with beta-2-microglobulin and the peptide-loading complex, including tapasin and ERAP1. Peptide binding stabilizes the MHC class I complex, which then traffics through the Golgi to the plasma membrane. The dynamics of MHC-I molecules in this pathway are critical for efficient antigen presentation.
Cross-presentation and autophagy contributions
In simple terms: Some cells can also present antigens from dead cells or from their own recycled components, adding to the repertoire.
Cross-presentation allows dendritic cells to present exogenous antigens on MHC class I, and DNGR-1 signaling for phagosomal rupture promotes this process for dead-cell-associated antigens. Autophagy also contributes to endogenous antigen processing and presentation, delivering cytosolic antigens to MHC class II and influencing cross-presentation. These pathways expand the range of endogenous antigens that can be displayed.
Regulation and immune evasion
In simple terms: The pathway can be turned up or down, and tumors often shut it down to hide from the immune system.
Antigen processing and presentation is regulated at multiple levels, including interferon signaling and transcriptional control of MHC and proteasome genes. Tumors frequently acquire defects in this pathway to evade CD8+ T cell recognition, and bacterial pathogens can modulate antigen processing and presentation to alter host immunity. Understanding these regulatory mechanisms is important for immunotherapy design.
Key Genes Involved in GO:0019883 antigen processing and presentation of endogenous antigen
The following genes encode proteins that are central to endogenous antigen processing and presentation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-A | MHC class I heavy chain; presents endogenous peptides to CD8+ T cells | Target for knockout to study antigen presentation and immune evasion |
| HLA-B | MHC class I heavy chain; presents endogenous peptides | Polymorphisms influence epitope repertoire and disease associations |
| HLA-C | MHC class I heavy chain; presents endogenous peptides | Regulates NK cell education and T cell responses |
| B2M | Beta-2-microglobulin; essential for MHC class I stability and surface expression | Frequent target of loss-of-function mutations in tumors |
| TAP1 | Transports peptides into the endoplasmic reticulum for MHC class I loading | Defects impair antigen presentation and are linked to immune evasion |
| TAP2 | Transports peptides into the endoplasmic reticulum for MHC class I loading | Mutations affect peptide supply and MHC class I surface levels |
| PSMB8 | Immunoproteasome subunit; generates peptides for MHC class I | Knockout models reveal altered epitope generation |
| PSMB9 | Immunoproteasome subunit; generates peptides for MHC class I | Modulates antigen processing efficiency |
| ERAP1 | Trims peptides in the endoplasmic reticulum for optimal MHC class I binding | Polymorphisms associated with autoimmune diseases |
| TAPBP | Tapasin; bridges TAP and MHC class I for peptide loading | Required for efficient peptide loading and surface presentation |
| CANX | Calnexin; chaperone in MHC class I assembly | Supports folding and quality control of MHC class I |
| CALR | Calreticulin; chaperone in MHC class I assembly | Facilitates peptide loading complex function |
| PDIA3 | Protein disulfide isomerase; part of the peptide-loading complex | Influences MHC class I peptide loading |
| DNGR-1 (CLEC9A) | Senses dead cells and promotes phagosomal rupture for cross-presentation | Knockout models study cross-presentation of dead-cell antigens |
| ATG5 | Autophagy-related protein; contributes to antigen presentation | Autophagy knockout affects endogenous antigen presentation |
| ATG7 | Autophagy-related protein; contributes to antigen presentation | Autophagy knockout affects endogenous antigen presentation |
| LAMP1 | Lysosomal-associated membrane protein; involved in antigen delivery | Marker for autophagic and endosomal antigen processing |
How Is antigen processing and presentation of endogenous antigen Regulated?
Antigen processing and presentation of endogenous antigen is regulated at multiple levels. Interferon signaling induces the expression of MHC class I, TAP, and immunoproteasome subunits, enhancing the pathway. Transcriptional control of MHC class I genes and antigen processing machinery components is critical for immune surveillance. Autophagy provides an additional layer of regulation by delivering cytosolic antigens to MHC class II and influencing cross-presentation. Bacterial pathogens can modulate antigen processing and presentation to evade host immunity. The dynamics of MHC-I molecules in the pathway are also regulated by chaperones and peptide-loading complex components.
antigen processing and presentation of endogenous antigen and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B2M | Cancer immune evasion; loss leads to MHC class I deficiency | B2M knockout tumor cell lines |
| TAP1 | Impaired antigen presentation; immune evasion | TAP1 knockout cell models |
| ERAP1 | Autoimmune disease associations; altered peptide trimming | ERAP1 point mutation knock-in models |
| HLA-A | Altered epitope presentation; cancer and autoimmunity | HLA-A knockout or knock-in cell lines |
| ATG5 | Autophagy-related antigen presentation defects | ATG5 knockout models |
Cancer immune evasion
Defects in antigen processing and presentation are a common mechanism of tumor immune evasion. Loss of B2M, TAP1, or MHC class I expression prevents CD8+ T cell recognition and can confer resistance to immune checkpoint blockade. Understanding these defects is essential for developing cancer vaccines and immunotherapies that overcome antigen presentation barriers.
Autoimmunity and central tolerance
Endogenous antigen presentation in the thymus is critical for central tolerance induction, and alterations in this process can contribute to autoimmunity. Polymorphisms in ERAP1 and MHC class I genes have been associated with autoimmune diseases, highlighting the importance of peptide processing in immune regulation.
Infectious disease and bacterial modulation
Bacterial pathogens can modulate antigen processing and presentation to evade host immune responses, as reviewed in the context of bacterial infections. This modulation can affect the outcome of infection and the development of protective immunity.
Placental and tumor establishment
Antigen processing and presentation pathways are important in both tumor and placenta establishment, where immune evasion mechanisms share features. This highlights the broader biological significance of endogenous antigen presentation beyond infection and cancer.
From antigen processing and presentation of endogenous antigen-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of B2M abolish endogenous antigen presentation? | B2M knockout cell line |
| How does a specific ERAP1 polymorphism affect peptide trimming? | ERAP1 point mutation knock-in |
| Can a tagged MHC class I molecule track surface presentation? | Tagged HLA-A knock-in |
| Does overexpression of TAP1 enhance antigen presentation? | TAP1 overexpression cell line |
| What is the role of DNGR-1 in cross-presentation? | DNGR-1 knockout dendritic cells |
| Does autophagy contribute to endogenous antigen presentation? | ATG5 or ATG7 knockout cells |
How to Study the antigen processing and presentation of endogenous antigen Process
| Method | What It Measures | Typical Application |
|---|---|---|
| T-Scan | Genome-wide T cell epitope discovery | Identifying endogenous antigens recognized by T cells |
| CRISPR knockout screening | Loss-of-function effects on antigen presentation | Discovering regulators of MHC class I presentation |
| Flow cytometry | Surface MHC class I levels | Assessing antigen presentation capacity |
| Immunopeptidomics | Peptide repertoire bound to MHC | Characterizing endogenous peptide antigens |
| Autophagy flux assays | Autophagic activity | Linking autophagy to antigen presentation |
| Cross-presentation assays | T cell activation by cross-presented antigens | Studying DNGR-1-dependent pathways |
| Bioinformatics analysis | Pathway enrichment and mutation impact | Interpreting genomic data in antigen presentation |
Genome-wide T cell epitope discovery
T-Scan is a genome-wide method for systematic discovery of T cell epitopes, enabling unbiased identification of endogenous antigens recognized by T cells. This approach is valuable for understanding the repertoire of peptides presented by MHC molecules.
MHC-I dynamics and imaging
Studying the dynamics of MHC-I molecules in the antigen processing and presentation pathway provides insights into peptide loading and surface trafficking. Imaging and biochemical approaches can reveal how MHC-I molecules move through the secretory pathway.
Autophagy and cross-presentation assays
Autophagy and cross-presentation can be studied using knockout models and functional assays to measure antigen-specific T cell activation. These methods help dissect the contribution of autophagy to endogenous antigen presentation.
CRISPR screening and bioinformatics
CRISPR library screening combined with bioinformatics can identify genes that regulate antigen processing and presentation. Such screens are powerful for discovering novel modulators of the pathway.
How CRISPR Can Be Used to Study GO:0019883 antigen processing and presentation of endogenous antigen
Knockout
CRISPR knockout of genes such as B2M, TAP1, or HLA-A can abolish or reduce endogenous antigen presentation, providing causal evidence for their roles. Knockout cell lines are widely used to study immune evasion and T cell recognition.
Point Mutation
Point mutation knock-in models, such as for ERAP1 polymorphisms, allow researchers to study how specific amino acid changes affect peptide trimming and antigen presentation. These models are valuable for linking genetic variants to functional outcomes.
Knock-in
Tagged knock-in of MHC class I genes enables tracking of surface presentation and intracellular trafficking. Knock-in of specific peptide epitopes can also be used to study T cell responses.
Overexpression
Overexpression of antigen processing components, such as TAP1 or immunoproteasome subunits, can enhance endogenous antigen presentation and is useful for studying pathway activation. Overexpression models help identify rate-limiting steps.
How EDITGENE Supports antigen processing and presentation of endogenous antigen Research
Researchers studying antigen processing and presentation of endogenous antigen-related genes often need to determine whether a candidate gene is causally involved in peptide generation, transport, or MHC loading. EDITGENE provides CRISPR-based cell models and screening services to enable such causal studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for antigen processing and presentation of endogenous antigen research.
Frequently Asked Questions About antigen processing and presentation of endogenous antigen
What is antigen processing and presentation of endogenous antigen?
It is the process by which an antigen-presenting cell expresses endogenous peptide or lipid antigens on its surface in association with an MHC protein complex, as defined by GO:0019883.
What genes are involved in antigen processing and presentation of endogenous antigen?
Key genes include HLA-A, HLA-B, HLA-C, B2M, TAP1, TAP2, PSMB8, PSMB9, ERAP1, and TAPBP, among others.
How does endogenous antigen presentation differ from exogenous antigen presentation?
Endogenous presentation uses antigens derived from within the cell, typically loaded onto MHC class I, while exogenous presentation uses antigens taken up from outside the cell, often loaded onto MHC class II.
What is the role of MHC class I in endogenous antigen presentation?
MHC class I molecules bind endogenous peptides and display them on the cell surface for recognition by CD8+ T cells.
How is endogenous antigen presentation studied experimentally?
Methods include CRISPR knockout screens, T-Scan for epitope discovery, immunopeptidomics, and flow cytometry for surface MHC levels.
Why is endogenous antigen presentation important in cancer?
Tumors often evade immune detection by defective antigen processing and presentation, making this pathway a target for cancer immunotherapy.
What is cross-presentation and how does it relate to endogenous antigen presentation?
Cross-presentation allows dendritic cells to present exogenous antigens on MHC class I, and it can intersect with endogenous pathways through mechanisms such as DNGR-1 signaling.
Does autophagy contribute to endogenous antigen presentation?
Yes, autophagy contributes to antigen processing and presentation, including delivery of cytosolic antigens to MHC class II and influencing cross-presentation.
Can bacteria modulate antigen processing and presentation?
Yes, bacterial pathogens can modulate antigen processing and presentation to alter host immune responses.
What CRISPR models are available for studying endogenous antigen presentation?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as B2M, TAP1, HLA-A, and ERAP1.
Conclusion
GO:0019883 antigen processing and presentation of endogenous antigen is a central biological process for immune surveillance and tolerance. Its molecular players, including MHC class I, B2M, TAP, and immunoproteasome subunits, are critical for CD8+ T cell recognition of infected and malignant cells. Dysregulation of this pathway contributes to cancer immune evasion, autoimmunity, and infectious disease outcomes. CRISPR-based cell models and genome-wide screening approaches provide powerful tools to dissect the mechanisms and regulation of endogenous antigen presentation.
References
- 1. Klein L et al.. 2025. Antigen presentation for central tolerance induction.. Nat Rev Immunol 25(1):57-72 PMID: 39294277
- 2. Huber F et al.. 2026. Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development.. Nat Rev Immunol 26(1):23-34 PMID: 40781552
- 3. Truong HV et al.. 2021. Dynamics of MHC-I molecules in the antigen processing and presentation pathway.. Curr Opin Immunol 70:122-128 PMID: 34153556
- 4. Kula T et al.. 2019. T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes.. Cell 178(4):1016-1028.e13 PMID: 31398327
- 5. Reeves E et al.. 2017. Tumour and placenta establishment: The importance of antigen processing and presentation.. Placenta 56:34-39 PMID: 28274545
- 6. Canton J et al.. 2021. The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens.. Nat Immunol 22(2):140-153 PMID: 33349708
- 7. Münz C. 2006. Autophagy and antigen presentation.. Cell Microbiol 8(6):891-8 PMID: 16681832
- 8. Maksymowych WP et al.. 2000. Bacterial modulation of antigen processing and presentation.. Microbes Infect 2(2):199-211 PMID: 10742692
